Browse the full insider trade history of CLARIANE SE, a listed issuer based in France. Shares are quoted on FR FR, under the authority of AMF. Operating in the Healthcare & Pharma sector, CLARIANE SE has recorded 46 reports. Market capitalisation: €1.5bn. The latest transaction was filed on 7 May 2026 — Acquisition. Among the most active insiders: HLD Europe SCA. The full history is accessible without an account.
FY ended December 2025 · cache
25 of 46 declarations
Clariane SE is a leading European provider of care, healthcare and hospitality services for vulnerable people, with a core focus on ageing, dependency and medically complex care needs. The company, historically known as Korian, was founded in France in 2003 and rebranded as Clariane in 2023 as part of a broad strategic transformation. That transformation was accompanied by the adoption of purpose-driven company status, with a mission to “take care of each person’s humanity in times of vulnerability,” now embedded in its corporate governance and long-term strategy. Clariane’s business model is built around two complementary divisions: Long-Term Care and Specialty Care. Long-Term Care comprises medically assisted nursing homes, senior living solutions and related accommodation services for elderly residents. Specialty Care covers a wide range of healthcare services, including psychiatric care, post-acute and rehabilitation services, day hospitalisation, outpatient pathways and home-based or proximity care. This integrated model allows the group to address the full patient journey, from residential support to more specialised medical treatment. The group has a substantial European footprint across six countries: France, Germany, Belgium, Italy, the Netherlands and Spain. According to its corporate disclosures, Clariane operates 1,215 facilities and employs around 70,000 people, serving 840,000 residents and patients. This scale gives it a strong market presence in a sector that is both highly local and highly regulated, while also exposing it to differences in reimbursement systems, labour costs and healthcare policy across countries. From a strategic and financial perspective, Clariane has been reshaping its portfolio since 2023 through a major balance-sheet strengthening plan and divestment programme. In 2025, the company stated that it had completed that plan six months ahead of schedule, helping it refocus on its two core businesses. For full-year 2024, revenue reached €5.282 billion, up 6.6% on an organic basis, showing solid underlying operational momentum despite a challenging environment. Clariane also emphasises human capital, training and social impact. It launched Clariane University in France to support skills development across care professions, and in 2026 it received Top Employer Europe certification for the third consecutive year. Together with its mission-led status and sustainability commitments, these initiatives support the company’s positioning as a major European care platform aligned with structural demographic tailwinds.